Literature DB >> 33627079

Clinical characteristics of coronavirus disease 2019 (COVID-19) in patients out of Wuhan from China: a case control study.

Hua Zhang1, Zhen-Peng Huang2, Feng Du3, Xiao-Jun Cao1, Xia-Long Feng4, He-Ping Zhang1, Zheng-Xia Wu1, Bao-Feng Wang1, Hong-Juan Zhang1, Rui Liu1, Jian-Jun Yang3, Bo Ning3, Kai Chen5.   

Abstract

BACKGROUND: A large-scale global outbreak of coronavirus disease-19 (COVID-19) out of Wuhan, from China, occurred in January 2020. To examine the clinical characteristics of COVID-19 in infected patients out of Wuhan, from China.
METHODS: Thirteen patients were confirmed to be infected with novel coronavirus-2019 (2019-nCoV) between January 27 and February 8, 2020, in Baoji city, Shannxi, northwestern China. Epidemiological and clinical information, and computed to morphology imaging data from all COVID-19 patients were collected; cases were divided into two groups according to the severity of infection (mild or severe).
RESULTS: Nine (9/13) COVID-19 patients exhibited mild disease severity, and defined as second-generation human-to-human transmission cases. Most patients (11/13) had a history of travel to or from Wuhan. There were no differences in sex and age between the mild and severe cases (all P > 0.05). A moderate degree of fever (11/13), cough (13/13), and fatigue (8/13) were common symptoms; however, there was no statistical difference between mild and severe cases in this regard (all P > 0.05). Oxyhemoglobin saturation and oxygenation index decreased, and C-reactive protein (CRP) and serum amyloid A (SAA) levels were elevated in all patients with COVID-19 infection, with statistically significant differences between those with severe disease and mild infection (all P < 0.05). Twelve of 13 COVID-19 patients exhibited changes in chest CT imaging features, and time course changes were different between mild and severe cases (all P < 0.05).
CONCLUSION: Most cases of COVID-19 infection were second-generation human-to-human transmissions from Wuhan and were mild in severity. The clinical characteristics of COVID-19 varied. Oxyhemoglobin saturation, oxygenation index, CRP and SAA levels, and CT features were reliable parameters to evaluate the severity of COVID-19 infection. However, a few patients with mild COVID-19 disease lacked typical characteristics such as fever and changes in CT imaging features.

Entities:  

Keywords:  2019-nCoV; COVID-19; China; Clinical characteristics; Wuhan

Year:  2021        PMID: 33627079     DOI: 10.1186/s12879-021-05897-z

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  2 in total

1.  Endolymphatic-mastoid shunt operation: results of the 24 cases and revision surgery with the silastic sheet.

Authors:  K Gyo; N Yanagihara
Journal:  Auris Nasus Larynx       Date:  1982       Impact factor: 1.863

2.  A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).

Authors:  Ying-Hui Jin; Lin Cai; Zhen-Shun Cheng; Hong Cheng; Tong Deng; Yi-Pin Fan; Cheng Fang; Di Huang; Lu-Qi Huang; Qiao Huang; Yong Han; Bo Hu; Fen Hu; Bing-Hui Li; Yi-Rong Li; Ke Liang; Li-Kai Lin; Li-Sha Luo; Jing Ma; Lin-Lu Ma; Zhi-Yong Peng; Yun-Bao Pan; Zhen-Yu Pan; Xue-Qun Ren; Hui-Min Sun; Ying Wang; Yun-Yun Wang; Hong Weng; Chao-Jie Wei; Dong-Fang Wu; Jian Xia; Yong Xiong; Hai-Bo Xu; Xiao-Mei Yao; Yu-Feng Yuan; Tai-Sheng Ye; Xiao-Chun Zhang; Ying-Wen Zhang; Yin-Gao Zhang; Hua-Min Zhang; Yan Zhao; Ming-Juan Zhao; Hao Zi; Xian-Tao Zeng; Yong-Yan Wang; Xing-Huan Wang
Journal:  Mil Med Res       Date:  2020-02-06
  2 in total
  8 in total

Review 1.  Animal models for COVID-19: advances, gaps and perspectives.

Authors:  Changfa Fan; Yong Wu; Xiong Rui; Yuansong Yang; Chen Ling; Susu Liu; Shunan Liu; Youchun Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

Review 2.  Hypertonic Solution in Severe COVID-19 Patient: A Potential Adjuvant Therapy.

Authors:  Matheus Gennari-Felipe; Leandro Borges; Alexandre Dermargos; Eleine Weimann; Rui Curi; Tania Cristina Pithon-Curi; Elaine Hatanaka
Journal:  Front Med (Lausanne)       Date:  2022-06-21

3.  Comparison of laboratory parameters in mild vs. severe cases and died vs. survived patients with COVID-19: systematic review and meta-analysis.

Authors:  Budao Cao; Xuefen Jing; Yan Liu; Rong Wen; Cuifeng Wang
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

4.  A rapid lateral flow immunoassay strip for detection of SARS-CoV-2 antigen using latex microspheres.

Authors:  Lin Shen; Qihan Zhang; Xiaolu Luo; Haolin Xiao; Miao Gu; Liangli Cao; Feijun Zhao; Zhencheng Chen
Journal:  J Clin Lab Anal       Date:  2021-11-06       Impact factor: 2.352

5.  Safe water supply challenges for hand hygiene in the prevention of COVID-19 in Southern Nations, Nationalities, and People's Region (SNNPR), Ethiopia.

Authors:  Mekonnen Birhanie Aregu; Girum Gebremeskel Kanno; Zemachu Ashuro; Awash Alembo; Addisu Alemayehu
Journal:  Heliyon       Date:  2021-11-19

6.  Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study.

Authors:  Hamid Reza Kouhpayeh; Farhad Tabasi; Mohammad Dehvari; Mohammad Naderi; Gholamreza Bahari; Tahereh Khalili; Courtney Clark; Saeid Ghavami; Mohsen Taheri
Journal:  Transl Med Commun       Date:  2021-11-17

7.  Clinical Features and Time to Recovery of Admitted COVID-19 Cases at Dilla University Referral Hospital Treatment Center, South Ethiopia.

Authors:  Gemechu Churiso; Kuma Diriba; Henok Girma; Soressa Tafere
Journal:  Infect Drug Resist       Date:  2022-03-04       Impact factor: 4.003

8.  Comorbidities associated with risk of ICU admission in elderly patients with COVID-19: Data from academic hospital in Saudi Arabia.

Authors:  Saad Alsaad; Abdurahman Addweesh; Mohammed Beyari; Munib Alkhateb; Abdulrahman Alswat; Abdulrahman Alshabnan; Abdulaziz Alsaad; Haytham AlSaif
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.